These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
590 related articles for article (PubMed ID: 6488167)
1. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver. Kari FW; Kauffman FC; Thurman RG Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167 [TBL] [Abstract][Full Text] [Related]
2. Effect of bile salts on rates of formation, accumulation, and export of mutagenic metabolites from benzo(a)pyrene produced by the perfused rat liver. Kari FW; Kauffman FC; Thurman RG Cancer Res; 1985 Apr; 45(4):1621-7. PubMed ID: 3978630 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of glucuronidation of benzo(a)pyrene phenols by long-chain fatty acids. Zhong Z; Kauffman FC; Thurman RG Cancer Res; 1991 Sep; 51(17):4511-5. PubMed ID: 1908348 [TBL] [Abstract][Full Text] [Related]
4. Benzo(a)pyrene phenol production by perfused rat liver and its inhibition by ethanol. Reinke LA; McManus P; Kauffman FC; Thurman RG Cancer Res; 1982 May; 42(5):1681-5. PubMed ID: 6279282 [TBL] [Abstract][Full Text] [Related]
5. Effect of fatty acids on formation, distribution, storage, and release of benzo(a)pyrene phenols and glucuronides in the isolated perfused rat liver. Zhong Z; Gao W; Kauffman FC; Thurman RG Cancer Res; 1989 Apr; 49(8):2012-6. PubMed ID: 2702643 [TBL] [Abstract][Full Text] [Related]
6. Metabolism and biliary excretion of benzo[a]pyrene 4,5-oxide in the rat. Plummer JL; Smith BR; Ball LM; Bend JR Drug Metab Dispos; 1980; 8(2):68-72. PubMed ID: 6103790 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of uptake and biliary excretion of benzo(alpha)pyrene and mutagenic metabolites in isolated perfused rat liver. Forti GC; Trieff NM Teratog Carcinog Mutagen; 1980; 1(3):269-82. PubMed ID: 6119817 [TBL] [Abstract][Full Text] [Related]
8. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene. Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446 [TBL] [Abstract][Full Text] [Related]
9. Mutagenic activation of biliary metabolites of benzo(a)pyrene by beta-glucuronidase-positive bacteria in human faeces. Nanno M; Morotomi M; Takayama H; Kuroshima T; Tanaka R; Mutai M J Med Microbiol; 1986 Dec; 22(4):351-5. PubMed ID: 3795254 [TBL] [Abstract][Full Text] [Related]
10. The formation of genotoxic metabolites of benzo[a]pyrene by the isolated perfused rat liver, as detected by the bioluminescence test. Ben-Itzhak J; Levi BZ; Shor R; Lanir A; Bassan HM; Ulitzur S Mutat Res; 1985 Jun; 147(3):107-12. PubMed ID: 4000152 [TBL] [Abstract][Full Text] [Related]
11. Effect of dietary lipid on benzo(a)pyrene metabolism by perfused rat liver. Lam TC; Wade AE Drug Nutr Interact; 1981; 1(1):31-44. PubMed ID: 6926814 [TBL] [Abstract][Full Text] [Related]
12. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives. Utesch D; Glatt H; Oesch F Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447 [TBL] [Abstract][Full Text] [Related]
13. Comparative metabolism of benzo(a)pyrene and covalent binding to hepatic DNA in English sole, starry flounder, and rat. Varanasi U; Nishimoto M; Reichert WL; Le Eberhart BT Cancer Res; 1986 Aug; 46(8):3817-24. PubMed ID: 3731058 [TBL] [Abstract][Full Text] [Related]
14. Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity. Wiersma DA; Roth RA J Pharmacol Exp Ther; 1983 Apr; 225(1):121-5. PubMed ID: 6300370 [TBL] [Abstract][Full Text] [Related]
15. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides. Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of benzo(a)pyrene and benzo (a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes. Wood AW; Levin W; Lu AY; Yagi H; Hernandez O; Jerina DM; Conney AH J Biol Chem; 1976 Aug; 251(16):4882-90. PubMed ID: 821945 [TBL] [Abstract][Full Text] [Related]
17. Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver. Zhong Z; Goto M; Hijioka T; Oide H; Kauffman FC; Thurman RG Drug Metab Dispos; 1994; 22(5):680-7. PubMed ID: 7835217 [TBL] [Abstract][Full Text] [Related]
18. Systemic excretion of benzo(a)pyrene in the control and microsomally induced rat: the influence of plasma lipoproteins and albumin as carrier molecules. Shu HP; Bymun EN Cancer Res; 1983 Feb; 43(2):485-90. PubMed ID: 6293698 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of 3-benzo[a]pyrenyl glucuronide hydrolysis by calcium activation of microsomal beta-glucuronidase. Whittaker M; Sokolove PM; Thurman RG; Kauffman FC Cancer Lett; 1985 Mar; 26(2):145-52. PubMed ID: 3978604 [TBL] [Abstract][Full Text] [Related]
20. Mutagenic activity of biliary metabolites of 6-hydroxymethylbenzo[a]pyrene. Hughes MF; Kadry AR; Gairola CG; Flesher JW Mutat Res; 1986 Apr; 173(4):251-6. PubMed ID: 3513004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]